<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="1137" OLDID="16457" TOPICS="YES">
<DATE> 3-MAR-1987 11:50:25.33</DATE>
<TOPICS><D>earn</D></TOPICS>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f0897 reute
d f BC-NORTH-AMERICAN-BIOLOG   03-03 0075</UNKNOWN>
<TEXT> 
<TITLE>NORTH AMERICAN BIOLOGICALS INC &lt;NBIO&gt; 4TH QTR</TITLE>
<DATELINE>    MIAMI, March 3 -
    </DATELINE><BODY>Oper shr one ct vs three cts
    Oper net 99,000 vs 327,000
    Revs 12.1 mln vs 8,800,000
    Avg shrs 15.5 mln vs 11.3 mln
    Year
    Oper shr six cts vs 11 cts
    Oper net 841,000 vs 956,000
    Revs 44.1 mln vs 34.4 mln
    Avg shrs 15.3 mln vs 8,519,677
    NOTE: Net excludes tax credits of 299,000 dlrs vs 29,00000
dlrs in quarter and 809,000 dlrs vs 71,000 dlrs in year.
 Reuter
 </BODY></TEXT>
</REUTERS>